Home Antidiabetic activities of aerial part of Asparagus racemosus Willd. extract: an in vitro, in vivo, and in silico approach
Article
Licensed
Unlicensed Requires Authentication

Antidiabetic activities of aerial part of Asparagus racemosus Willd. extract: an in vitro, in vivo, and in silico approach

  • Priya Das , Ankrita Thapa , Suraj Mistri , Gouhar Jahan Ashraf , Sourav Sarkar , Debabrata Modak , Soumen Bhattacharjee , Ravi Kumar Singh , Tarun Kumar Dua ORCID logo , Paramita Paul , Gouranga Nandi and Ranabir Sahu ORCID logo EMAIL logo
Published/Copyright: February 10, 2025
Become an author with De Gruyter Brill

Abstract

Asparagus racemosus Willd., a significant medicinal plant in India’s Darjeeling Himalayan region. The current study aims to assess the antidiabetic efficacy of the aerial part of Asparagus racemosus Willd. utilizing a streptozotocin-nicotinamide-induced diabetic rat model. The methanolic extract of plant (ARME) was evaluated for in vitro antidiabetic activity through α-glucosidase and α-amylase enzyme suppression assay and assessed in vivo in a streptozotocin-induced rat model. A 21-day chronic multiple-dose study of ARME was examined. STZ-induced diabetic rats were treated with metformin (70 mg/kg) and ARME at concentrations of 200 and 400 mg/kg. It was discovered that ARME inhibited the activities of α-amylase and α-glucosidase and showed potent therapeutic effects on the rat’s model. ARME helps raise body weight, hemoglobin, and other blood counts and normalizes the serum parameters in the diabetic group. In addition, liver tissues’ abnormal levels of the antioxidant enzymes glutathione and lipid peroxides were returned to those of control animals. HPTLC study revealed the presence of stigmasterol, which showed a strong affinity for the proteins linked to diabetes mellitus through in silico study. As a result of these findings, ARME inhibits the activity of digestive enzymes and has antioxidant and antihyperglycemic effects in STZ-nicotinamide-induced diabetic rats.


Corresponding author: Ranabir Sahu, Department of Pharmaceutical Technology, University of North Bengal, Darjeeling, 734013, West Bengal, India, E-mail:

Award Identifier / Grant number: 2323/R-2022

Award Identifier / Grant number: SRG/2019/001910

Award Identifier / Grant number: No. F. 587 30-515/2020(BSR);12/02/2020

Acknowledgments

We are grateful to the University of North Bengal for providing facilities for research.

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: The financial support of SERB-SRG (file no. SRG/2019/001910), India, UGC-SRG [No. F. 30-515/2020(BSR);12/02/2020], India and the University assistance/support for the research project (Ref. No. 2323/R-2022), University of North Bengal, India are greatly acknowledged.

  7. Data availability: Not applicable.

References

1. Jaiswal, Y, Tatke, P, Gabhe, S, Vaidya, A. Antidiabetic activity of extracts of Anacardium occidentale Linn. leaves on n-streptozotocin diabetic rats. J Tradit Complementary Med2017;7:421–7. https://doi.org/10.1016/j.jtcme.2016.11.007.Search in Google Scholar PubMed PubMed Central

2. Rahimi, R, Nikfar, S, Larijani, B, Abdollahi, M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005;59:365–73. https://doi.org/10.1016/j.biopha.2005.07.002.Search in Google Scholar PubMed

3. Galicia-Garcia, U, Benito-Vicente, A, Jebari, S, Larrea-Sebal, A, Siddiqi, H, Uribe, KB, et al.. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21:6275. https://doi.org/10.3390/ijms21176275.Search in Google Scholar PubMed PubMed Central

4. Zaccardi, F, Webb, DR, Yates, T, Davies, MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med 2016;92:63–9. https://doi.org/10.1136/postgradmedj-2015-133281.Search in Google Scholar PubMed

5. Patra, S, Bhattacharya, S, Bala, A, Haldar, PK. Antidiabetic effect of Drymaria cordata leaf against streptozotocin–nicotinamide-induced diabetic albino rats. J Adv Pharm Technol Research (JAPTR) 2020;11:44. https://doi.org/10.4103/japtr.japtr_98_19.Search in Google Scholar PubMed PubMed Central

6. Asmat, U, Abad, K, Ismail, K. Diabetes mellitus and oxidative stress—a concise review. Saudi Pharmaceut J 2016;24:547–53. https://doi.org/10.1016/j.jsps.2015.03.013.Search in Google Scholar PubMed PubMed Central

7. Rashid, U, Khan, MR, Sajid, M. Antioxidant, anti-inflammatory and hypoglycemic effects of Fagonia olivieri DC on STZ-nicotinamide induced diabetic rats-in vivo and in vitro study. J Ethnopharmacol 2019;242:112038. https://doi.org/10.1016/j.jep.2019.112038.Search in Google Scholar PubMed

8. Sharma, VK, Kumar, S, Patel, HJ, Hugar, S. Hypoglycemic activity of Ficus glomerata in alloxan induced diabetic rats. Int J Pharmaceut Sci Rev Res 2010;1:18–22.Search in Google Scholar

9. Mohajan, D, Mohajan, HK. Oral hypoglycaemic agents: non-insulin medications for type 2 diabetes patients. Innov Sci Technol 2024;3:23–31. https://doi.org/10.56397/ist.2024.01.04.Search in Google Scholar

10. Kaleem, M, Medha, P, Ahmed, Q, Asif, M, Bano, B. Beneficial effects of Annona squamosa extract in streptozotocin-induced diabetic rats. Singap Med J 2008;49:800.Search in Google Scholar

11. Kuroe, A, Taniuguchi, A, Fukushima, M, Nakai, Y, Ohgushi, M, Ohya, M, et al.. Early and late onset side effects of short-acting insulin analogue in seven Japanese diabetic patients. Diabetes Res Clin Pract 2007;77:412–13. https://doi.org/10.1016/j.diabres.2006.12.019.Search in Google Scholar PubMed

12. Ganie, SY, Javaid, D, Singh, A, Jawaid, F, Anjum, S, Kumari, M, et al.. Chemoprofiling and in vitro evaluation of anticancer, antioxidant and antibacterial activities of Asparagus racemosus (Willd). Pharmacol Res Nat Prod 2024;2:100015. https://doi.org/10.1016/j.prenap.2024.100015.Search in Google Scholar

13. Majumdar, S, Gupta, S, Prajapati, SK, Krishnamurthy, S. Neuro-nutraceutical potential of Asparagus racemosus: a review. Neurochem Int 2021;145:105013. https://doi.org/10.1016/j.neuint.2021.105013.Search in Google Scholar PubMed

14. Das, P, Ashraf, GJ, Baishya, T, Dua, TK, Paul, P, Nandi, G, et al.. High‐performance thin‐layer chromatography coupled attenuated total reflectance‐Fourier‐transform infrared and NMR spectroscopy‐based identification of α‐amylase inhibitor from the aerial part of Asparagus racemosus Willd. Phytochem Anal 2022;33:1018–27. https://doi.org/10.1002/pca.3155.Search in Google Scholar PubMed

15. Goyal, R, Singh, J, Lal, H. Asparagus racemosus – an update. Indian J Med Sci 2003;57:408–14.Search in Google Scholar

16. Hasan, N, Ahmad, N, Zohrameena, S, Khalid, M, Akhtar, J. Asparagus racemosus: for medicinal uses & pharmacological actions. Int J Adv Res 2016;4:259–67.Search in Google Scholar

17. Singla, R, Jaitak, V. Shatavari (Asparagus racemosus Wild): a review on its cultivation, morphology, phytochemistry and pharmacological importance. Int J Pharm Life Sci 2014;5.Search in Google Scholar

18. Wong, F-C, Yong, A-L, Ting, EP-S, Khoo, S-C, Ong, H-C, Chai, T-T. Antioxidant, metal chelating, anti-glucosidase activities and phytochemical analysis of selected tropical medicinal plants. Iran J Pharm Res (IJPR) 2014;13:1409.Search in Google Scholar

19. Chaimum-aom, N, Chomko, S, Talubmook, C. Toxicology and oral glucose tolerance test (OGTT) of Thai medicinal plant used for diabetes controls, Phyllanthus acidus L. (Euphorbiaceae). Pharmacogn J 2017;9.10.5530/pj.2017.1.11Search in Google Scholar

20. Reza, MS, Shuvo, MSR, Hassan, MM, Basher, MA, Islam, MA, Naznin, NE, et al.. Antidiabetic and hepatoprotective potential of whole plant extract and isolated compounds of Aeginetia indica. Biomed Pharmacother 2020;132:110942. https://doi.org/10.1016/j.biopha.2020.110942.Search in Google Scholar PubMed

21. Masiello, P, Broca, C, Gross, R, Roye, M, Manteghetti, M, Hillaire-Buys, D, et al.. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224–9. https://doi.org/10.2337/diabetes.47.2.224.Search in Google Scholar

22. Chandran, R, Parimelazhagan, T, Shanmugam, S, Thankarajan, S. Antidiabetic activity of Syzygium calophyllifolium in streptozotocin-nicotinamide induced Type-2 diabetic rats. Biomed Pharmacother 2016;82:547–54. https://doi.org/10.1016/j.biopha.2016.05.036.Search in Google Scholar PubMed

23. Shirwaikar, A, Rajendran, K, Punitha, I. Antidiabetic activity of alcoholic stem extract of Coscinium fenestratum in streptozotocin-nicotinamide induced type 2 diabetic rats. J Ethnopharmacol 2005;97:369–74. https://doi.org/10.1016/j.jep.2004.11.034.Search in Google Scholar PubMed

24. Oliyaei, N, Moosavi‐Nasab, M, Tamaddon, AM, Tanideh, N. Antidiabetic effect of fucoxanthin extracted from Sargassum angustifolium on streptozotocin‐nicotinamide‐induced type 2 diabetic mice. Food Sci Nutr 2021;9:3521–9. https://doi.org/10.1002/fsn3.2301.Search in Google Scholar PubMed PubMed Central

25. Ghatani, K, Thapa, S, Sha, SP, Sarkar, S, Modak, D, Bhattacharjee, S. Revealing probiotic potential of enterococcus strains isolated from traditionally fermented chhurpi and healthy human gut. Front Microbiol 2022;13:909987. https://doi.org/10.3389/fmicb.2022.909987.Search in Google Scholar PubMed PubMed Central

26. Draper, HH, Hadley, M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990;186:421–31. https://doi.org/10.1016/0076-6879(90)86135-i.Search in Google Scholar PubMed

27. Aebi, H. Catalase. In: Methods of enzymatic analysis. Cambridge: Elsevier; 1974:673–84 pp.10.1016/B978-0-12-091302-2.50032-3Search in Google Scholar

28. Gl, E. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–7. https://doi.org/10.1016/0003-9861(59)90090-6.Search in Google Scholar PubMed

29. Das, P, Ashraf, GJ, Baishya, T, Dua, TK, Paul, P, Nandi, G, et al.. In vitro pharmacological evaluation, phytochemical profiling, and in silico molecular docking of Duabanga grandiflora leaves and flowers. Vegetos 2023:1–13. https://doi.org/10.1007/s42535-023-00742-x.Search in Google Scholar

30. Maleki, S, Falsafi, P, Pakdel, F, Eslami, H, Ahari, UZ, Pouralibaba, F, et al.. A comparison between catalase and salivary alpha-amylase level in patients with type I diabetes and non-diabetic people. Biomed Pharmacol J 2016;9:463–8. https://doi.org/10.13005/bpj/959.Search in Google Scholar

31. Arunachalam, K, Parimelazhagan, T. Antidiabetic activity of Ficus amplissima Smith. bark extract in streptozotocin induced diabetic rats. J Ethnopharmacol 2013;147:302–10. https://doi.org/10.1016/j.jep.2013.03.004.Search in Google Scholar PubMed

32. Thent, ZC, Lin, TS, Das, S, Zakaria, Z. Histological changes in the heart and the proximal aorta in streptozotocin-induced diabetic rats following Piper sarmentsoum administration. Afr J Tradit, Complementary Altern Med 2012;9:396–404.10.4314/ajtcam.v9i3.15Search in Google Scholar

33. Atmakuri, LR, Dathi, S. Current trends in herbal medicines. J Pharm Res 2010;3:109–13.Search in Google Scholar

34. Bakrim, S, Benkhaira, N, Bourais, I, Benali, T, Lee, LH, El Omari, N, et al.. Health benefits and pharmacological properties of stigmasterol. Antioxidants 2022;11. https://doi.org/10.3390/antiox11101912.Search in Google Scholar PubMed PubMed Central

35. Vadivelan, R, Krishnan, RG, Kannan, R. Antidiabetic potential of Asparagus racemosus Willd leaf extracts through inhibition of α-amylase and α-glucosidase. J Trad Complement Med 2019;9:1–4. https://doi.org/10.1016/j.jtcme.2017.10.004.Search in Google Scholar PubMed PubMed Central

36. Hossain, U, Das, AK, Ghosh, S, Sil, PC. An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications. Food Chem Toxicol 2020;145:111738. https://doi.org/10.1016/j.fct.2020.111738.Search in Google Scholar PubMed PubMed Central

37. Ćorković, I, Gašo-Sokač, D, Pichler, A, Šimunović, J, Kopjar, M. Dietary polyphenols as natural inhibitors of α-amylase and α-glucosidase. Life 2022;12:1692. https://doi.org/10.3390/life12111692.Search in Google Scholar PubMed PubMed Central

38. Kifayatullah, M, Mustafa, MS, Sengupta, P, Sarker, MMR, Das, A, Das, SK. Evaluation of the acute and sub-acute toxicity of the ethanolic extract of Pericampylus glaucus (Lam.) Merr. in BALB/c mice. J Acute Dis 2015;4:309–15. https://doi.org/10.1016/j.joad.2015.06.010.Search in Google Scholar

39. Matteucci, E, Giampietro, O. Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research. J Ethnopharmacol 2008;115:163–72. https://doi.org/10.1016/j.jep.2007.08.040.Search in Google Scholar PubMed

40. Lenzen, S. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia 2008;51:216–26. https://doi.org/10.1007/s00125-007-0886-7.Search in Google Scholar PubMed

41. Su, H-C, Hung, L-M, Chen, J-K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metabol 2006;290:E1339–46. https://doi.org/10.1152/ajpendo.00487.2005.Search in Google Scholar PubMed

42. Chi, T-C, Chen, W-P, Chi, T-L, Kuo, T-F, Lee, S-S, Cheng, J-T, et al.. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci 2007;80:1713–20. https://doi.org/10.1016/j.lfs.2007.02.002.Search in Google Scholar PubMed

43. Pupim, LB, Heimbürger, O, Qureshi, AR, Ikizler, TA, Stenvinkel, P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 2005;68:2368–74. https://doi.org/10.1111/j.1523-1755.2005.00699.x.Search in Google Scholar PubMed

44. Eleazu, CO, Iroaganachi, M, Okafor, PN, Ijeh, II, Eleazu, KC. Ameliorative potentials of Ginger (Z. officinale Roscoe) on relative organ weights in streptozotocin induced diabetic rats. Int J Biomed Sci 2013;9:82–90. https://doi.org/10.59566/ijbs.2013.9082.Search in Google Scholar

45. Feleke, MK, Bekele, T, Dessie, G, Ayelgn, T, Nigatu, A, Jemere, T, et al.. Effect of Justicia schimperiana (Acanthaceae) roots extract on blood glucose level and lipid profiles in streptozotocin-induced diabetic mice. Metabolism Open 2024;21:100270. https://doi.org/10.1016/j.metop.2024.100270.Search in Google Scholar PubMed PubMed Central

46. Chandran, R, Sathyanarayanan, S, Rajan, M, Kasipandi, M, Parimelazhagan, T. Antioxidant, hypoglycemic and antihyperglycemic properties of Syzygium calophyllifolium. Bangladesh J Pharmacol 2015;10:672–80. https://doi.org/10.3329/bjp.v10i3.23361.Search in Google Scholar

47. Pillai, KK, Chidambaranathan, N, Halith, MM, Jayaprakash, S, Narayanan, N. Anti-hyperglycemic effect of alcoholic extracts of Cnidoscolus chayamansa in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. Int J Res Pharm Chem 2012;2:179–87.Search in Google Scholar

48. Hannan, J, Rokeya, B, Faruque, O, Nahar, N, Mosihuzzaman, M, Khan, AA, et al.. Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of Type 2 diabetic model rats. J Ethnopharmacol 2003;88:73–7. https://doi.org/10.1016/s0378-8741(03)00190-9.Search in Google Scholar PubMed

49. Maghrani, M, Lemhadri, A, Jouad, H, Michel, J-B, Eddouks, M. Effect of the desert plant Retama raetam on glycaemia in normal and streptozotocin-induced diabetic rats. J Ethnopharmacol 2003;87:21–5. https://doi.org/10.1016/s0378-8741(03)00104-1.Search in Google Scholar PubMed

50. Sachdewa, A, Khemani, L. Effect of Hibiscus rosa sinensis Linn. ethanol flower extract on blood glucose and lipid profile in streptozotocin induced diabetes in rats. J Ethnopharmacol 2003;89:61–6. https://doi.org/10.1016/s0378-8741(03)00230-7.Search in Google Scholar PubMed

51. Alahmer, S, El-Noss, M, Farid, A. Preparation of chitosan nanoparticles loaded with Balanites aegyptiaca extract for treatment of streptozotocin-induced diabetes in rats. Int J Biol Macromol 2024:130061. https://doi.org/10.1016/j.ijbiomac.2024.130061.Search in Google Scholar PubMed

52. Almalki, DA, Alghamdi, SA, Al-Attar, AM. Comparative study on the influence of some medicinal plants on diabetes induced by streptozotocin in male rats. BioMed Res Int 2019;2019:3596287. https://doi.org/10.1155/2019/3596287.Search in Google Scholar PubMed PubMed Central

53. Mori, DM, Baviera, AM, de Oliveira Ramalho, LT, Vendramini, RC, Brunetti, IL, Pepato, MT. Temporal response pattern of biochemical analytes in experimental diabetes. Biotechnol Appl Biochem 2003;38:183–91. https://doi.org/10.1042/ba20030034.Search in Google Scholar

54. Kennedy, AL, Lyons, TJ. Glycation, oxidation, and lipoxidation in the development of diabetic complications. Metabolism 1997;46:14–21. https://doi.org/10.1016/s0026-0495(97)90311-5.Search in Google Scholar PubMed

55. Bandyopadhyay, U, Das, D, Banerjee, RK. Reactive oxygen species: oxidative damage and pathogenesis. Curr Sci 1999:658–66.Search in Google Scholar

56. Mannangatti, V, Ayyasamy, B, Rangasamy, M, Kumar, N. Antioxidant potential of ethanolic extract of Bauhinia tomentosa (Linn) flower. Res J Pharmaceut Biol Chem Sci 2010;1:143–7.Search in Google Scholar

57. Ashraf, GJ, Das, P, Dua, TK, Paul, P, Nandi, G, Sahu, R. High‐performance thin‐layer chromatography based approach for bioassay and ATR–FTIR spectroscopy for the evaluation of antioxidant compounds from Asparagus racemosus Willd. aerial parts. Biomed Chromatogr 2021;35:e5230. https://doi.org/10.1002/bmc.5230.Search in Google Scholar PubMed

58. Vo Van, L, Pham, EC, Nguyen, CV, Ntn, D, Vi Le Thi, T, Truong, TN. In vitro and in vivo antidiabetic activity, isolation of flavonoids, and in silico molecular docking of stem extract of Merremia tridentata (L.). Biomed Pharmacother 2022;146:112611. https://doi.org/10.1016/j.biopha.2021.112611.Search in Google Scholar PubMed

59. Cubbon, RM, Kearney, MT, Wheatcroft, SB. Endothelial IGF-1 receptor signalling in diabetes and insulin resistance. Trends Endocrinol Metabol 2016;27:96–104. https://doi.org/10.1016/j.tem.2015.11.009.Search in Google Scholar PubMed

60. Nauck, MA, Vardarli, I, Deacon, CF, Holst, JJ, Meier, JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011;54:10–18. https://doi.org/10.1007/s00125-010-1896-4.Search in Google Scholar PubMed

61. Rangwala, SM, Lazar, MA. Peroxisome proliferator-activated receptor γ in diabetes and metabolism. Trends Pharmacol Sci 2004;25:331–6. https://doi.org/10.1016/j.tips.2004.03.012.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/znc-2024-0142).


Received: 2024-06-13
Accepted: 2025-01-18
Published Online: 2025-02-10

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 14.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2024-0142/html
Scroll to top button